Sigma Healthcare Withdraws From Boots Sale Process

Sigma Healthcare withdrew from the Boots sale process, ending its pursuit of the British pharmacy chain in a deal valued up to $10 billion. The Australian company said the acquisition would not meet its strategic and capital investment objectives. Sigma shares rose as much as 8% on the news.